Shanxi Tianli Hengde Pharmaceutical Technology Co., Ltd. signed an equity transfer agreement to acquire 51% stake in Shanxi Jianghe Tonghui Medical Equipment Co., Ltd. from Thalys Medical Technology Group Corporation (SHSE:603716) for CNY 0.55 million in March 2023.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.05 CNY | +1.59% | -7.24% | -36.43% |
1st Jan change | Capi. | |
---|---|---|
-36.43% | 181M | |
-3.36% | 1.38B | |
-9.37% | 1.32B | |
-15.29% | 1.07B | |
-19.53% | 845M | |
-1.15% | 463M | |
+1.81% | 434M | |
-50.00% | 373M | |
-24.35% | 335M | |
-3.26% | 210M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Shanxi Tianli Hengde Pharmaceutical Technology Co., Ltd. signed an equity transfer agreement to acquire 51% stake in Shanxi Jianghe Tonghui Medical Equipment Co., Ltd. from Thalys Medical Technology Group Corporation for CNY 0.55 million.